乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Lung Cancer

News, opinions and meeting coverage in oncology/hematology.

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC

Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

However, plinabulin plus docetaxel still "not ready for prime time," expert says

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Absolute improvement of almost 30%, doubling of duration of response with savolitinib

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

Two-trial analysis shows about a 40% decreased risk of disease recurrence or death

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

Novel agent nearly halved risk of progression as first-line therapy in phase III trial

WCLC over a photo of San Diego Conference Center in San Diego, CA.

<乌鸦传媒>Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

News, features, and commentary about cancer-related issues

A photo composite of vials of Opdivo and Yervoy over a computer rendering of lung cancer.

<乌鸦传媒>Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity

A CT scan of healthy lungs.

<乌鸦传媒>Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Alternate criteria based on years of smoking has higher sensitivity and specificity, study says

FDA APPROVED lazertinib (Lazcluze) over a computer rendering of lung cancer.

<乌鸦传媒>Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib

A photo of a box of prednisolone tablets.

<乌鸦传媒>Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggests

More data for discussion of controversial association between steroids, immunotherapy

FDA APPROVED durvalumab (Imfinzi) over a computer rendering of a transparent body with lung cancer highlighted.

<乌鸦传媒>FDA Expands Durvalumab Label to Operable Lung Cancer

PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

News, features, and commentary about cancer-related issues

A computer rendered cutaway of a colonoscopy.

<乌鸦传媒>Cancer Screening Costs Over $43 Billion a Year in the U.S., Study Estimates

Colorectal cancer screening accounted for 64% of the total amount

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk

News, features, and commentary about cancer-related issues

FDA ODAC durvalumab (Imfinzi) over a computer rendering of an antibody attacking lung cancer cells.

<乌鸦传媒>FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Committee unanimously backs mandating trial design to distinguish effects of therapy phases

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

News, features, and commentary about cancer-related issues

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

News, features, and commentary about cancer-related issues

<乌鸦传媒>Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

Discussion highlights insights from the LAURA trial and others on emerging treatments

A close up photo of a man smoking an ecigarette.

<乌鸦传媒>Vapers May Be Less Likely to Undergo Lung Cancer Screening

"Former smokers who use e-cigarettes remain at increased risk of lung cancer," researchers say

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

News, features, and commentary about cancer-related issues

A computer rendering of a liver under a red umbrella.

<乌鸦传媒>Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury

Case reports may not be as reliable, researchers say

A photo of the HealthCare.gov website.

<乌鸦传媒>Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverage

Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

News, features, and commentary about cancer-related issues

A computer rendering of a transparent body with a tumor in the lungs highlighted.

<乌鸦传媒>Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response

A close up photo of a woman smoking a cigarette.

<乌鸦传媒>Early Menopause Tied to Higher Risk of Respiratory Mortality

Greatest risk observed for women with bilateral oophorectomy

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

News, features, and commentary about cancer-related issues

A computer rendering of a lung tumor.

<乌鸦传媒>Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Half of patients responded, but editorialists call for new directions in therapy development

A scanning electron microscope image of a dendritic cell

<乌鸦传媒>Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Immunotherapy may have been given too late, researchers suggested

An advertisement for lung cancer screening on the back of a kiosk in New York City.

<乌鸦传媒>Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South

But one study showed that patient navigation added to usual care may increase uptake

<乌鸦传媒>Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients

Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial

News, features, and commentary about cancer-related issues

A photo of a male Johnson & Johnson researcher writing chemical formulas on glass with a marker.

Industry Clinic 鈥� Ad Insights

<乌鸦传媒>What Will It Take to Deliver Both Health & Care in Oncology?

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab

Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>'Practice Changing' Trial for Inoperable Locally Advanced NSCLC

EGFR testing now needed for all patients with stage III disease, experts say

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer

No differences observed in quality of life metric, patient and caregiver satisfaction

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC

Unexpectedly offers a possible overall survival benefit, researchers say

ASCO over a photo of McCormick Place in Chicago, IL

<乌鸦传媒>Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents

China-based trial may present a hurdle to FDA approval, however

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

News, features, and commentary about cancer-related issues

1

鈥�